Literature DB >> 16504494

Relationship between exhaled nitric oxide levels and compliance with inhaled corticosteroids in asthmatic children.

Maria Katsara1, Deidrie Donnelly, Shaique Iqbal, Tracy Elliott, Mark L Everard.   

Abstract

Levels of exhaled nitric oxide (eNO) are elevated in subjects with asthma and fall in response to oral or inhaled steroids. This study explored the possibility the measurement of eNO levels could be used to identify subjects who were not adhering to their treatment regimen. Twenty children with asthma attending the respiratory clinic were recruited. Each attended on four occasions 1 month apart when eNO levels were measured. A data logger attached to a pressurised metered dose inhaler was used to objectively monitor use of inhaled corticosteroids (ICSs). The correlation between day and dose compliance with eNO was assessed. The data demonstrated a weak but non-significant correlation between eNO and both day (r = 0.055, P = 0.67) and dose (r = 0.153, P = 0.23). A recorded value of eNO less than 12 was associated with day compliance rates of 3-97%. Of the 19 recorded eNO values greater than 12 ppb almost 80% were from subjects with a day compliance of less than 50% during the preceding month. Of the four values greater than 12 ppb and day compliance > 60% one subject had a poor inhaler technique, one had a mild viral exacerbation and one appeared to be associated with increase pollen exposure. The measurement of eNO may prove to be a useful tool in helping to manage children with asthma but further work is required to define its precise role. Elevated eNO levels in asthmatic children taking ICSs are likely to reflect poor compliance but confounding factors such as disease activity and inhaler technique need to be carefully considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16504494     DOI: 10.1016/j.rmed.2006.01.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

1.  Fractional Exhaled Nitric Oxide-Assisted Management of Uncontrolled Persistent Asthma: A Real-World Prospective Observational Study.

Authors:  Robert Stephen Zeiger; Michael Schatz; Su-Jau Yang; Wansu Chen
Journal:  Perm J       Date:  2019

Review 2.  Exhaled nitric oxide: a test for diagnosis and control of asthma?

Authors:  Rohit Katial; Lora Stewart
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

3.  Exhaled nitric oxide in stable chronic obstructive pulmonary disease.

Authors:  Mohammed F S Beg; Mohammad A Alzoghaibi; Abdullah A Abba; Syed S Habib
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

4.  Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC).

Authors:  Enrico Heffler; Giovanna Elisiana Carpagnano; Elisabetta Favero; Giuseppe Guida; Mauro Maniscalco; Andrea Motta; Giovanni Paoletti; Giovanni Rolla; Eugenio Baraldi; Vincenza Pezzella; Giorgio Piacentini; Stefano Nardini
Journal:  Multidiscip Respir Med       Date:  2020-02-19

Review 5.  Assessment of adherence to corticosteroids in asthma by drug monitoring or fractional exhaled nitric oxide: A literature review.

Authors:  Fahad Alahmadi; Adam Peel; Brian Keevil; Rob Niven; Stephen J Fowler
Journal:  Clin Exp Allergy       Date:  2020-11-27       Impact factor: 5.018

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.